Related Experiment Video
Updated: May 26, 2026
16:38
Bridging the Bio-Electronic Interface with Biofabrication
Published on: June 6, 2012
AI for bioactive materials: From material design to biological applications.
Jiezhong Shi1,2, Ting Liang3, Marcin Heljak4
1SINOPEC Key Laboratory of Research and Application of Medical and Hygienic Materials, SINOPEC Beijing Research Institute of Chemical Industry Co., Ltd., Beijing, 100013, PR China.
Bioactive Materials
|May 25, 2026
Summary
Artificial intelligence (AI) offers powerful solutions for designing advanced bioactive materials. This review explores AI applications in material design, fabrication, and assessment, overcoming complex biological challenges.
Area of Science:
- Biomaterials Science
- Materials Engineering
- Computational Biology
Background:
- Bioactive materials actively engage with biological systems to promote desired cellular and tissue outcomes.
- Developing these materials is complex, often exceeding the capabilities of traditional high-throughput and simulation methods.
- Artificial intelligence (AI) presents advanced data-driven tools to address these complexities.
Purpose of the Study:
- To provide a comprehensive overview of artificial intelligence applications in the field of bioactive materials.
- To systematically review recent advancements and methodologies.
- To discuss current challenges and future directions in AI-driven bioactive material development.
Main Methods:
- Classification of bioactive materials (metals, ceramics, polymers, composites).
- Categorization of AI tools used in bioactive materials research.
- Analysis of process-oriented AI applications: design, fabrication, property prediction, and biological assessments (in vitro and in vivo).
Main Results:
- AI reveals intricate relationships in experimental data, enabling accurate material behavior prediction.
- AI facilitates the rational design of novel bioactive materials with tailored properties.
- AI tools are being applied across the entire lifecycle of bioactive materials, from initial design to biological evaluation.
Conclusions:
- AI is a transformative technology for overcoming the challenges in bioactive material development.
- Data-driven AI models enhance material design, optimization, and prediction capabilities.
- Future opportunities lie in further integrating AI to accelerate the discovery and application of advanced bioactive materials.
Related Concept Videos
01:13Bioavailability: Overview
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...